Since we demonstrated that GBM cells propagated in Esm1 KO and WT mice showed substantial and highly persistent phenotypic differences, we hypothesized that Endocan-PDGFRA signaling can induce stable epigenetic alterations. The gene discussed is ESM1; the disease is glioblastoma.